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Over the past decade, there has been a marked increase in
the use of arterial conduits to perform coronary artery bypass
grafting (CABG).1 The clinical and survival benefits of bilat-
eral internal thoracic artery grafts have established them as
conduits of first choice for CABG,2 whereas the radial artery
has rapidly become the third most commonly used arterial
conduit.3
The radial artery is a versatile conduit, which can be har-
vested easily and safely, has handling characteristics superior
to those of other arterial grafts, and comfortably reaches any
coronary target. Several studies3 have reported superior paten-
cy of radial artery grafts compared with vein grafts at up to 5
years after CABG. Enthusiasm for widespread use of the radi-
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al artery as a conduit for CABG has, however, been tempered
by its greater proclivity to spasm in the perioperative period.
This can result in severe postoperative myocardial hypoperfu-
sion, as well as adversely affecting the grafts long-term paten-
cy.3 The capacity of the radial artery for vasospasm is several-
fold greater than that of the internal thoracic artery4 because of
its more muscular media, and this risk is further increased in
patients who require inotropic or vasoconstrictor therapy.
Various pharmacologic maneuvers5-8 have been recom-
mended to reduce the risk of radial artery vasospasm in the
perioperative period, but all have significant limitations.
Intravenous infusions of calcium channel blockers5 cause
hypotension, bradycardia, and significant rhythm distur-
bances, whereas the topically applied agents, such as
papaverine6 and nitroglycerin,7 have relatively short half-
lives. The elegant technique of adenoviral transfer of
endothelial nitric oxide synthetase to prevent radial artery
spasm8 is not yet ready for clinical application.
To minimize the perioperative risk of radial artery spasm,
we irrigate the harvested artery internally and externally with
a solution of 100 mg of phenoxybenzamine in 50 mL of warm
heparinized blood before anastomosis. Phenoxybenzamine is
a nonselective α-adrenoceptor antagonist with a half-life of
approximately 24 hours, which covalently and irreversibly
binds to its target receptor.9 There is, however, no report of its
use or efficacy as a topical vasodilatatory agent in the prepa-
ration of arterial conduits for CABG.
Patients. Left radial arteries were harvested (standard tech-
niques) from 10 patients undergoing CABG by using only
Hartmann solution.
Methods. One inch of the distal (wrist) radial artery was
excised and placed into chilled (4°C, pH 7.4) N-2-hydroxy-
ethylpiperazine-N-2-ethanesulfonic acid (HEPES)–buffered
physiologic saline solution (PSS) and transported, in a 20-
minute bicycle ride, from the John Radcliffe Hospital to the
University Laboratory of Physiology. Specimens were then
immediately transferred to warmed (37°C) PSS (recipe as
above but with 24 mmol/L NaHCO3 and no HEPES) and bub-
bled with 95% oxygen and 5% carbon dioxide to maintain a
pH of 7.4. These conditions were maintained throughout all
subsequent stages of the experiment, except for the brief peri-
ods required for transferring the vessels or changing solutions.
Vessel mounting and normalization. Arteries were placed
in organ baths and mounted onto hooks with transducers
attached to an automated myograph (AM10; Cambustion
Biological, Cambridge, United Kingdom). The theory and
protocol have been described by Mulvany and Halpern.10
Initial tension was set to be equivalent to 100 mm Hg, accord-
ing to the Laplace relation.
Experimental protocol. To determine their viability, we first
constricted vessels with PSS containing 75 mmol/L KCl and
then with a 5-minute exposure to 1 mmol/L epinephrine. The
vessels were then incubated for 1 hour in the presence of the
irreversible α−adrenergic blocker phenoxybenzamine (1
mg/mL) and subsequently tested for constriction with a 10-
minute exposure to epinephrine. After the effectiveness of
phenoxybenzamine was determined, the viability of the vessel
and that of its endothelium were tested with 75 mmol/L KCl
followed by acetylcholine or its synthetic analog carbachol. If
the constriction of a vessel by this second KCl challenge was
greater than 80% of the first response, and if acetylcholine or
carbachol relaxed the vessel, it was considered to be in good
condition. The protocol is illustrated in Fig 1.
Analysis. A Dell (386) microcomputer was used with
Cambustion software (1991) to digitize tension at 1 Hz. Data
were plotted by using a custom-written Turbo Pascal micro-
computer program and Microsoft Excel software. The latter
was used to normalize each trace to the baseline and peak ten-
sions obtained in response to the first addition of KCl.
Results. Results for the 10 individual radial artery seg-
ments are presented in Fig 1. All arterial segments demon-
strated marked constriction to KCl, which resolved when the
Fig 1. The effects of phenoxybenzamine on 10 radial arteries. Response of radial artery to KCl and epinephrine
(Adrenaline) before and after phenoxybenzamine administration. ACh, Acetylcholine.
KCl was removed with PSS. Exposure of the arterial seg-
ments to epinephrine produced marked constriction, which
was abolished by the addition of phenoxybenzamine. After
exposure to phenoxybenzamine, the segments did not con-
strict when re-exposed to epinephrine. However, subsequent
exposure of the segments to KCl produced further constric-
tion, which was reversed by the addition of acetylcholine or
carbachol, confirming the viability of the vessel and its
endothelium.
Discussion. Our observations demonstrate that phenoxy-
benzamine abolishes adrenergic-mediated vasoconstriction
of the radial artery without producing irreversible damage to
the vessel or its endothelium.
Although our study is based on samples of radial arteries
from only 10 patients, the results are remarkably consistent.
The empiric use of 100 mg of phenoxybenzamine in 50 mL
of heparinized blood is consistent with the in vitro dose-
response curve, showing a maximal radial artery vasodilato-
ry response with 1 mg/mL phenoxybenzamine.
Advantages of topical phenoxybenzamine in clinical prac-
tice are its relatively long half-life (24 hours) in comparison
with other vasodilators,5-8 whereas its topical application
eliminates adverse systemic effects. Similarly, avoidance of
intravenous calcium antagonists obviates the significant
hemodynamic problems they can cause in patients undergo-
ing CABG. Although our study does not answer how long the
effect of phenoxybenzamine persists, this is likely to be sev-
eral days because the drug binds irreversibly to α-receptors,
necessitating the growth of new receptors before the vessel
regains its responsiveness to adrenergic agonists.
Equally important, our study suggests that phenoxybenza-
mine does not significantly damage the radial artery because
it retains its responsiveness to both KCl and acetylcholine.
Our findings may have significant implications for increas-
ing the safety and scope of radial artery use in clinical prac-
tice. By preventing radial artery vasospasm, phenoxybenza-
mine abolishes, or at least significantly reduces the risk of,
perioperative myocardial hypoperfusion. It has allowed us to
expand the use of the radial artery to those patients who are
likely to require modest inotropic support in the perioperative
period and in particular to patients receiving angiotensin-con-
verting enzyme inhibitor medication who frequently require
vasoconstrictors to maintain systemic blood pressure.11
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